159 related articles for article (PubMed ID: 9123930)
1. Incidence of hepatitis C virus RNA in anti-HCV-negative plasma pools and blood products.
Saldanha J; Minor P
Vox Sang; 1996; 70(4):232-4. PubMed ID: 9123930
[No Abstract] [Full Text] [Related]
2. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
Alvarez M; Planelles D; Vila E; Montoro J; Franco E
Vox Sang; 2004 May; 86(4):266-7. PubMed ID: 15144533
[No Abstract] [Full Text] [Related]
3. Antibody testing and RT-PCR results in hepatitis C virus (HCV) infection: HCV-RNA detection in PBMC of plasma viremia-negative HCV-seropositive persons.
Caudai C; Padula MG; Bastianoni I; Valensin PE; Shyamala V; Han J; Boggiano CA; Almi P
Infection; 1998; 26(3):151-4. PubMed ID: 9646105
[TBL] [Abstract][Full Text] [Related]
4. An easy dipstick assay for anti-core antibodies to screen blood donors for hepatitis C virus viremia.
Mulyanto ; Suwignyo S; Tsauri S; Itoh K; Mizui M; Tsuda F; Okamoto H; Yoshizawa H; Mishiro S
Vox Sang; 1996; 70(4):229-31. PubMed ID: 9123929
[No Abstract] [Full Text] [Related]
5. Use of the Procleix HIV-1 and HCV discriminatory assays to detect HIV and HCV RNA in whole blood.
Tobler LH; Dockter J; Stramer SL; Kleinman SH; Todd D; Giachetti C; Busch MP
Transfusion; 2002 Nov; 42(11):1525-7. PubMed ID: 12421231
[No Abstract] [Full Text] [Related]
6. HCV positivity rate in the seronegative blood donors in China.
Yang Z; Han YX; Jiang JD; Yang Z; Yu YX; Qiu Y
Biomed Pharmacother; 2009 May; 63(4):319-20. PubMed ID: 19246175
[No Abstract] [Full Text] [Related]
7. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
[TBL] [Abstract][Full Text] [Related]
8. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
9. NAT yield for human immunodeficiency and hepatitis C viruses in Brazilian blood donors: preliminary results.
Andrea P; Kupek E; Genovez G; Martins JT; Barban GB
Transfus Med; 2015 Apr; 25(2):125-7. PubMed ID: 25720742
[No Abstract] [Full Text] [Related]
10. [Interpretation of hepatitis C virus serology: immunoblot and genome amplification].
Maniez-Montreuil M; Dubois F
Transfus Clin Biol; 2000 Jun; 7 Suppl 1():25s-30s. PubMed ID: 10919220
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus RNA viremia in Central Africa.
Cancré N; Grésenguet G; Mbopi-Kéou FX; Kozemaka A; Si Mohamed A; Matta M; Fournel JJ; Bélec L
Emerg Infect Dis; 1999; 5(3):484-5. PubMed ID: 10341195
[No Abstract] [Full Text] [Related]
12. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
Shuhart MC; Myerson D; Spurgeon CL; Bevan CA; Sayers MH; McDonald GB
Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.
Laperche S; Bouchardeau F; Maniez M; Béolet M; Elghouzzi MH; Lefrère JJ
Vox Sang; 2004 Apr; 86(3):198. PubMed ID: 15078255
[No Abstract] [Full Text] [Related]
14. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
[TBL] [Abstract][Full Text] [Related]
15. Use and interpretation of HCV diagnostic tests in the clinical setting.
Gretch DR
Clin Liver Dis; 1997 Nov; 1(3):543-57, vi. PubMed ID: 15560057
[TBL] [Abstract][Full Text] [Related]
16. Changing strategies for hepatitis C testing.
Teo CG
Antivir Ther; 2012; 17(7 Pt B):1391-5. PubMed ID: 23322655
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus RNA positivity among RIBA-3 indeterminates.
Jha J; Arankalle VA; Banerjee K
Vox Sang; 1995; 69(2):145-6. PubMed ID: 8585200
[No Abstract] [Full Text] [Related]
18. Is hepatitis C virus-RNA detection by nested polymerase chain reaction clinically relevant in hemodialysis patients?
Dussol B; de Lamballerie X; Brunet P; Roubicek C; Chicheportiche C; Cantaloube JF; Biagini P; de Micco P; Berland Y
Clin Nephrol; 1996 Apr; 45(4):257-60. PubMed ID: 8861802
[TBL] [Abstract][Full Text] [Related]
19. The value of HCV antigen test with reference to PCR in confirming infection in cases with indefinite antibody test result.
Seiskari T; Horsti J; Aittoniemi J
J Clin Virol; 2011 May; 51(1):90-1. PubMed ID: 21377410
[No Abstract] [Full Text] [Related]
20. High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis.
El-Sherif A; Elbahrawy A; Aboelfotoh A; Abdelkarim M; Saied Mohammad AG; Abdallah AM; Mostafa S; Elmestikawy A; Elwassief A; Salah M; Abdelbaseer MA; Abdelwahab KS
Hemodial Int; 2012 Jul; 16(3):420-7. PubMed ID: 22360424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
